Variation in Adenoma Detection Rate and the Lifetime Benefits and Cost of Colorectal Cancer Screening: A Microsimulation Model

scientific article

Variation in Adenoma Detection Rate and the Lifetime Benefits and Cost of Colorectal Cancer Screening: A Microsimulation Model is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1001/JAMA.2015.6251
P932PMC publication ID4631392
P698PubMed publication ID26080339

P50authorDouglas A. CorleyQ110251065
Virginia P QuinnQ113440142
Joanne E. SchottingerQ113446237
Chyke DoubeniQ43097306
Marjolein van BallegooijenQ47497320
Iris Lansdorp-VogelaarQ47497337
Ann ZauberQ56012057
Christopher JensenQ88392468
Reinier G S MeesterQ88917963
Theodore R LevinQ96185266
P2093author name stringMiriam P van der Meulen
P2860cites workSerrated lesions of the colorectum: review and recommendations from an expert panelQ26827208
Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of RadiologyQ28274937
Randomised controlled trial of faecal-occult-blood screening for colorectal cancerQ29999461
Screening colonoscopy and risk for incident late-stage colorectal cancer diagnosis in average-risk adults: a nested case-control studyQ30543607
Polyp miss rate determined by tandem colonoscopy: a systematic reviewQ33232976
Adenoma detection rate and risk of colorectal cancer and deathQ33677291
Analysis of administrative data finds endoscopist quality measures associated with postcolonoscopy colorectal cancerQ33696687
Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trialQ34112898
Risk of perforation after colonoscopy and sigmoidoscopy: a population-based studyQ34175299
Colonoscopic withdrawal times and adenoma detection during screening colonoscopyQ34590728
Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study WorkgroupQ34728738
Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statementQ34847160
Adverse events after outpatient colonoscopy in the Medicare populationQ34986998
Adjusting for patient demographics has minimal effects on rates of adenoma detection in a large, community-based settingQ35204667
Colorectal cancers soon after colonoscopy: a pooled multicohort analysisQ35249785
Prevalence and predictors of interval colorectal cancers in medicare beneficiaries.Q35673237
Polypectomy rate is a valid quality measure for colonoscopy: results from a national endoscopy databaseQ37339526
Long-term colorectal-cancer incidence and mortality after lower endoscopyQ37341827
Potentially inappropriate screening colonoscopy in Medicare patients: variation by physician and geographic regionQ37368910
Improving colonoscopy quality through health-care payment reformQ37765468
Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal CancerQ38023997
Polypectomy rate: a surrogate for adenoma detection rate varies by colon segment, gender, and endoscopistQ38169434
Can colonoscopy remain cost-effective for colorectal cancer screening? The impact of practice patterns and the Will Rogers phenomenon on costsQ39508977
Use of colonoscopy to screen asymptomatic adults for colorectal cancer. Veterans Affairs Cooperative Study Group 380.Q45190337
The Incidence and Cost of Unexpected Hospital Use After Scheduled Outpatient EndoscopyQ45980871
Colorectal testing utilization and payments in a large cohort of commercially insured US adultsQ46136488
Factors determining the quality of screening colonoscopy: a prospective study on adenoma detection rates, from 12,134 examinations (Berlin colonoscopy project 3, BECOP-3).Q47990052
Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood.Q50638892
Cost of care for elderly cancer patients in the United States.Q53730492
Reduced Risk of Colorectal Cancer Up to 10 Years After Screening, Surveillance, or Diagnostic ColonoscopyQ57191776
Probabilistic sensitivity analysis using Monte Carlo simulation. A practical approachQ69788749
Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findingsQ74016710
Colorectal cancers found after a complete colonoscopyQ80333308
Quality indicators for colonoscopy and the risk of interval cancerQ84210147
P433issue23
P407language of work or nameEnglishQ1860
P921main subjectcolorectal cancerQ188874
colorectal cancer screeningQ19391980
colorectal carcinomaQ25493920
P304page(s)2349-2358
P577publication date2015-06-01
P1433published inThe Journal of the American Medical AssociationQ1470970
P1476titleVariation in Adenoma Detection Rate and the Lifetime Benefits and Cost of Colorectal Cancer Screening: A Microsimulation Model
P478volume313

Reverse relations

cites work (P2860)
Q38680603"Evaluation of the EndoChoice full spectrum endoscopy (Fuse) platform for upper endoscopy and colonoscopy".
Q91600464A Nationwide Survey and Needs Assessment of Colonoscopy Quality Assurance Programs in the VA
Q36236085Colon adenoma features and their impact on risk of future advanced adenomas and colorectal cancer
Q50332490Colonoscopy surveillance for high risk polyps does not always prevent colorectal cancer.
Q40832385Colorectal Cancer Health Disparities and the Role of US Law and Health Policy
Q40416727Comparison of Colonoscopy Quality Measures Across Various Practice Settings and the Impact of Performance Scorecards
Q39745570Consequences of Increasing Time to Colonoscopy Examination After Positive Result From Fecal Colorectal Cancer Screening Test
Q39645380Constipation, fiber intake and non-compliance contribute to inadequate colonoscopy bowel preparation: a prospective cohort study
Q89452264Cost-utility of colorectal cancer screening at 40 years old for average-risk patients
Q44009661Editorial: On the Quality of Quality Metrics: Rethinking What Defines a Good Colonoscopy.
Q39237504Evaluation of the Effectiveness and Cost-Effectiveness of Personalized Surveillance After Colorectal Adenomatous Polypectomy.
Q60918840Evidence-based sizing of non-inferiority trials using decision models
Q94476193High-quality colon cleansing and multiple neoplasia detection with 1L NER1006 versus mid-volume options: Post hoc analysis of phase 3 clinical trials
Q38620941Impact of adenoma detection on the benefit of faecal testing vs. colonoscopy for colorectal cancer
Q55401196Impact of differences in adenoma and proximal serrated polyp detection rate on the long-term effectiveness of FIT-based colorectal cancer screening.
Q41005481Impact of feedback and monitoring on colonoscopy withdrawal times and polyp detection rates
Q36338676Observational methods to assess the effectiveness of screening colonoscopy in reducing right colon cancer mortality risk: SCOLAR.
Q53198625Optimizing Colonoscopy Quality: From Bowel Preparation to Surveillance.
Q89547362Predicting colorectal cancer risk from adenoma detection via a two-type branching process model
Q38816552The Effect of Right Colon Retroflexion on Adenoma Detection: A Systematic Review and Meta-analysis
Q94476199The importance of colonoscopy bowel preparation for the detection of colorectal lesions and colorectal cancer prevention
Q36354798Using predictions from a joint model for longitudinal and survival data to inform the optimal time of intervention in an abdominal aortic aneurysm screening programme

Search more.